Site Articles

Save the Date: Thursday, 17 October 2024 – Innovarte/KEI side event: Best and worst practices for limitations and exceptions to patent rights

Posted on by Thiru

Title: Best and worst practices for limitations and exceptions to patent rights Date: Thursday, 17 October 2024 Time: 13:00 CEST to 15:00 CEST Location: Room B, WIPO Registration link: https://wipo-int.zoom.us/meeting/register/u5Mtf-6vqz0jGdWIE2AObIjgN86Xuy4yqaKi Conveners: Innovarte and Knowledge Ecology International (KEI) On the margins… Continue Reading →

KEI Comments on NIH Exclusive License to Autala for Autoimmune Treatment

Posted on by Claire Cassedy

On September 3, 2024, Knowledge Ecology International (KEI) submitted comments to the NIH regarding the “Prospective Grant of an Exclusive Patent License: Dimethyl Synaptamide for the Treatment of Autoimmune Disorders and Inflammatory Diseases” (89 FR 66730). The Federal Register notice… Continue Reading →

KEI Joins Amicus Brief in CIR v. Dept of Labor case on FOIA and Transparency of Government Records

Posted on by Claire Cassedy

On July 17, 2024, Knowledge Ecology International (KEI) joined Universities Allied for Essential Medicines, Dr. Christopher Morten, and Dr. Reshma Ramachandran in submitting an amicus brief in the case of the Center for Investigative Reporting, et al. v. United States… Continue Reading →

KEI Comment to NIST on Transparency of March-in Proceedings

Posted on by KEI Staff

On December 8, 2023, the National Institute of Standards and Technology (NIST) issued a Request for Information regarding the “Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights” (88 FR 85593). Today KEI submitted comments to NIST regarding… Continue Reading →

Chile (on behalf of 62 countries) asks for a more transparent, inclusive process for civil society engagement in WHO negotiations of a pandemic treaty

Posted on by Thiru

On Monday, 17 July 2023, Chile, on behalf of a group of 62 WHO member states called for a more transparent, inclusive process for civil society engagement in the WHO negotiations of a pandemic treaty at the Intergovernmental Negotiating Body… Continue Reading →

Eric Sawyer December 13, 2021 Petition to HHS on Xtandi March-in Case

Posted on by Claire Cassedy

On December 13, 2021, Eric Sawyer filed this petition with the Department of Health and Human Services, asking to join an outstanding march-in petition on the patents for the prostate cancer drug enzalutamide, sold under the brand name Xtandi by… Continue Reading →

KEI requests an open compulsory license relating to Paxlovid in the Dominican Republic

Posted on by Luis Gil Abinader

On Friday, December 3, 2021, KEI requested an open public interest license to allow the exploitation of PF-07321332 (marketed in combination with ritonavir under the brand Paxlovid) in the Dominican Republic. PF-07321332, being developed by Pfizer, has shown promising results… Continue Reading →

Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license

Posted on by Luis Gil Abinader

Today the government of Bolivia and Biolyse, a company based in Canada, signed an agreement to acquire COVID-19 vaccines manufactured by the company, if Canada grants them a compulsory license. Biolyse is a manufacturer of cancer drugs with the potential… Continue Reading →